MT modulates PTEN-induced putative kinase 1 (PINK1) expression via the MT2/Akt/NF-κB pathway to inhibit neuronal apoptosis in neurodegenerative diseases [12]. This evidence concerns the gene MTNR1B and neurodegenerative disease.